AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ARROWHEAD PHARMACEUTICALS, INC. Director's Dealing 2025

Aug 12, 2025

31071_dirs_2025-08-12_b6647e4a-be63-4d04-9b2c-111803301a5d.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2025-04-15

Reporting Person: Apel Daniel Joseph (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	101200	Direct

Footnotes

F1: Includes a total of 100,000 restricted stock units, which will vest over four years.